Initial Experience Of Patients Treated In A Real-World Clinical Setting With Bevacizumab-Awwb: The First Fda-Approved Biosimilar To Bevacizumab.

81Background: Bevacizumab-awwb is the first anti-cancer biosimilar and the first biosimilar to bevacizumab approved by the FDA. It was launched in the United States on July 19, 2019. Bevacizumab-aw...